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Sawsan, A
p-acceptoAbstract Spectrophotometric procedures were presented for the determination of antihistaminic
drug, emedastine difumarate. The methods are based on the charge transfer complexation reaction
of the drug with p-acceptors; 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), chloranilic acid
(CA) and 7,7,8,8-tetracyanoquinodimethane (TCNQ). Different charge-transfer complexes and col-
ored radical anions were obtained. The formations of the colored complexes were utilized in the
development of simple, rapid and accurate spectrophotometric methods for the analysis of emedas-
tine in drug substance and products. Under the optimum reaction conditions, linear relationships
with good correlation coefﬁcients (0.9996–0.9999) were found between the absorbance at the rele-
vant maxima and the concentrations of emedastine in the range of 0.8–200 lg mL1. The limits of
detection ranged from 0.06 to 0.76 lg mL1. The molar absorptivities and association constants for
the colored complexes were evaluated using the Benesi–Hildebrand equation. The free energy
change (DG) and the enthalpy of formation (DH) as well as the entropy (DS) were also deter-
mined. The methods were successfully applied to analyze the drug formulation with mean recovery
percentages ± RSD% of 100.04 ± 0.59–100.22 ± 0.72. The results were compared favorably with
the ofﬁcial and reported methods.
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Emedastine difumarate is 1-(2-ethoxyethyl)-2-(hexahydro-4-
methyl-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
(The United States Pharmacopeia, 2013). It is a selective
H1-receptor antagonist, used in eye drops to treat allergic con-
junctivitis (Sweetman, 2007; Lowry et al., 1996; Sharif et al.,
1994a,b).ing Saud University.
rmination and thermodynamic studies of the charge transfer complexation of
3), http://dx.doi.org/10.1016/j.arabjc.2013.07.012
2 A.-R.A. Sawsan et al.Few analytical methods were reported for its determination
in pharmaceuticals and biological ﬂuids. These include High
Performance Liquid Chromatography (HPLC) with tandem
mass spectrometry detector using MALDI-TOF MS (Sharif
et al., 1994a,b; Takaya et al., 2000) and HPLC – radioreceptor
assay (Nihashi and Ishida, 2000).
The aim of the present study is the development of simple
and rapid spectrophotometric methods for the analysis of eme-
dastine in its pharmaceutical formulation. The association
constant and standard free energy change (DG) were studied
using the Benesi–Hildebrand plot. The kinetic study and ther-
modynamic parameters of the drug with TCNQ were also
determined.2. Experimental
2.1. Instrument
Shimadzu UV-1601 PC and Shimadzu UV–VIS 160 A dual-
beam spectrophotometers (Japan), with matched 1 cm quartz
cells are used.
2.1.1. Materials and reagents
All solvents used were of spectroscopic grade and bidistilled
water was used throughout the work. Emedastine difumarate
was kindly supplied from Chem Swiss, SIGMA Co., Egypt.
Its purity was found to be 99.00% according to The United
States Pharmacopeia (2013). Emedastine 0.05% ophthalmic
solution labeled to contain 0.5 mg emedastine difumarate per
1 mL (Batch No., 190409-F1, manufactured by SIGMA Co.
Egypt) was purchased from the local market. DDQ and CA
(Aldrich, Germany) 0.2% (w/v), were prepared in acetonitrile
and found to be stable for at least one week when stored in
refrigerator. TCNQ (Aldrich, Germany) 0.1% (w/v), was
freshly prepared in acetonitrile. Acetone, acetonitrile, 1,4-diox-
ane, ethanol, methanol (Merck Co., Germany), chloroform
(Fischer Scientiﬁc, UK), anhydrous Na2SO4, ammonia solu-
tion 33% (Adwic Co., Egypt) were used.
2.1.2. Emedastine difumarate standard solutions
Emedastine difumarate standard solution, 1 mg mL1 was pre-
pared in methanol. This stock solution was subsequently used
for preparing working standard solutions, 0.5 mg mL1 for
DDQ and, 0.08 mg mL1 for TCNQ using acetonitrile. Eme-
dastine 1 · 103 M solution was prepared by dissolving an
accurately weighed amount of 53.457 mg in 10 mL methanol.
The volume was completed to 100 mL with acetonitrile.2.2. General analytical procedures
2.2.1. Construction of calibration curves
Aliquots equivalent to 50.0–1000.0 lg or 200.0–2000.0 lg of
emedastine difumarate working standard solutions (0.5 or
1 mg mL1) were transferred into two separate series of
10 mL volumetric ﬂasks. To each series, 2.5 mL of each;
0.1% DDQ or 0.1% CA was added separately. Then the vol-
ume was completed with acetonitrile. The absorbance was
measured after about 20 and 5 min at 457 and 519 nm of
DDQ and CA, respectively, against the appropriate reagentPlease cite this article in press as: Sawsan, A.-R.A. et al., Spectrophotometric dete
emedastine difumarate with some p-acceptors. Arabian Journal of Chemistry (201blank. Plots of absorbance against drug concentration were
plotted and regression parameters were computed.
For TCNQ, into a series of stopper test tubes, aliquots of
working drug solution (0.08 mg mL1) equivalent to 8.0–
160.0 lg of emedastine were transferred, followed by 2.5 mL
of 0.1% of TCNQ solution and 2 mL acetonitrile. The tubes
were heated in a thermostatic water bath at 60 C for 30 min
then cooled and the content of each tube was transferred quan-
titatively into a 10 mL volumetric ﬂask and completed to the
mark with acetonitrile. The absorbance was measured at
841 nm against a reagent blank treated similarly. The absor-
bance was plotted against corresponding drug concentration
and the regression equations were calculated.
2.2.2. Determination of stoichiometry of the charge transfer
complex by Job’s method of continuous variation
Three series of 2 mL quantities of mixtures of equimolar solu-
tions of emedastine difumarate-DDQ, emedastine difumarate-
CA and emedastine difumarate-TCNQ were made. The ﬁrst
and third series were made from 1 · 103 M of each DDQ
and TCNQ and acceptor by compromising complementary
proportions of the two solutions (0.2:1.8, 0.4:1.6,.., 1.8:0.2)
in 10 mL volumetric ﬂasks and stopper test tubes for the ﬁrst
and third series, respectively. The second series was made by
the same procedure, using solutions of emedastine difumarate
and CA each of, 5 · 103 M in 10 mL volumetric ﬂasks. Then
the detailed procedures described under, ‘‘Construction of cal-
ibration curves’’, were followed. The absorbance was mea-
sured, at 457, 520 and 481 nm for the charge transfer
complexes of DDQ-emedastine, CA-emedastine and TCNQ-
emedastine, respectively each against its appropriate blank.
2.2.3. Determination of stability constant, molar absorptivity
and standard free energy change
Different volumes; 0.1–0.5 mL of 1 · 103 M solution of eme-
dastine in acetonitrile were transferred into a series of 10 mL
volumetric ﬂasks. To each ﬂask, 5 mL of 104 M DDQ or
CA in acetonitrile was added separately. For TCNQ, different
volumes; 0.1–0.5 mL of 1 · 103 M drug solution in acetoni-
trile were transferred into a series of 10 mL stopper test tubes.
Then 2 mL of 104 M TCNQ in acetonitrile was added. The
detailed procedures described under, ‘‘Construction of calibra-
tion curves’’, were followed for each method.
2.2.4. Determination of thermodynamic parameters of
emedastine-TCNQ complex
Into a series of stopper test tubes, aliquots of working solu-
tions of emedastine equivalent to 80 lg of emedastine were
transferred, followed by 2.5 mL of 0.1% TCNQ and 2 mL of
acetonitrile. The tubes were heated in a thermostatic water
bath at different temperatures (40, 50, 60 C) for different time
intervals. At the speciﬁed time intervals, the tubes were cooled
and the content of each tube was transferred quantitatively to
10 mL volumetric ﬂasks. Then the detailed procedures de-
scribed under ‘‘Construction of calibration curves’’, were
followed.2.2.5. Application to pharmaceutical formulations
An accurately measured volume of the mixed emedastine eye
drop solution (ﬁve bottles) equivalent to 10 mg of emedastinermination and thermodynamic studies of the charge transfer complexation of
3), http://dx.doi.org/10.1016/j.arabjc.2013.07.012
Spectrophotometric determination and thermodynamic studies of the charge transfer complexation 3difumarate was quantitatively transferred into a beaker and
evaporated under vacuum, then dissolved in 5 mL methanol
and transferred quantitatively to 10 mL volumetric ﬂask and
completed with acetonitrile, then ﬁltered and completed to
10 mL with acetonitrile. The procedure described under,
‘‘Construction of calibration curves’’, was followed.
3. Results and discussion
The molecular interactions between electron donors and elec-
tron acceptors are generally associated with the formation of
intensely colored charge-transfer complexes, which absorb
radiation in the visible region (Hamada et al., 1989). A variety
of electron donating compounds have been reported to yield
charge-transfer complexes leading to their utility in the devel-
opment of simple and convenient spectrophotometric methods
(Foster, 1969; Mohamed et al, 2007; Hasani and Akbari, 2007;
Wu and Du, 2007; Khaked, 2008; El-Zaria, 2008; El-Bagary
et al, 2012; Raza and Zia-Ul-Haq, 2011).
The molar absorptivities and association constants for the
colored complexes were evaluated using the Benesi–Hilde-
brand equation (Benesi and Hidelbrand, 1949).
The standard free energy was also calculated. The color
reaction between the studied drug and TCNQ is heat depen-
dant. Therefore, kinetic and thermodynamic parameters were
studied to establish the stability of the complex and the opti-
mum conditions for the complex formation. The values ob-
tained for these thermodynamic parameters indicated that
the complex formed between these two chemical entities (Eme-
dastine and TCNQ) is highly stable.
3.1. Spectral characteristics of the reaction
The absorption spectra of, emedastine difumarate in acetoni-
trile are shown in Fig. 1, where emedastine exhibits strong
band at 283 nm. The interaction of emedastine with the p
acceptors DDQ, CA and TCNQ yields charge transfer
complexes which are converted to intensity colored radical an-Wavelenght (nm)
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Figure 1 Zero order absorption spectra of, (a) emedastine
difumarate in acetonitrile (50 lg mL1), (b) emedastine difuma-
rate-DDQ CTC (50 lg mL1), (c) emedastine difumarate-CA
CTC (100 lg mL1) and (d) emedastine difumarate-TCNQ CTC
(8 lg mL1).
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maximally at 457, 519 and 841 nm, respectively, according to
the following scheme:
DþA! ðDAÞ
Complex
! Dþ þA
Radical ionsðin polar solventÞ3.2. Optimization of reaction conditions
3.2.1. Effect of reagent volume
Different volumes; 0.5–3.0 mL of each DDQ and CA (0.2%
w/v) and TCNQ (0.1% w/v) were studied. Highest absorbance
at the relevant maxima was obtained upon using 2.5 mL of each.
3.2.2. Effect of solvents
Different solvents were tried for the complexation reaction.
Acetonitrile afford maximum color intensity, which may be
attributed to its high dielectric constant that promotes maxi-
mum yield of radical anions, and its high solvating power
for p acceptors (Geffken and Salem, 2006).
3.2.3. Effect of time and temperature
Complete color development was attained instantaneously at
room temperature between drug and CA, which remained sta-
ble for further 1 h. For DDQ maximum absorbance was devel-
oped after 20 min and remained stable for further 15 min.
However, with TCNQ the complex formation was slow
over a period of two hr, which suggests heating at different
temperatures (40–60 C). The highest color intensity was at-
tained, after heating at 60 C for 30 min and remained stable
for further 25 min.
3.2.4. Stoichiometry of the reaction
On studying the molar ratio between drug and each of, DDQ,
CA and TCNQ, using Job’s method of continuous variation
for; 1 · 103 M solutions for DDQ, CA or TCNQ it was found
to be 1:1 (Rose, 1964), this indicates that only one site is
responsible for the formation of the complex and a univalent
charged species, is the possible site of the charge transfer
process.
3.2.5. Association constants and standard free energy
The association constants were calculated for the interaction
of emedastine with either DDQ, CA or TCNQ, using the Bene-
si–Hildebrand equation (Benesi and Hidelbrand, 1949) which
depends on the experimental conditions that one of the two
component species should be present in large excess, so that
its concentration is virtually unaltered on formation of the
complex.
½Ao
AAD
¼ 1
eAD
þ 1
eADKADC
X
1
½Do
where [AO] and [DO] are the total concentrations of the inter-
acting species (acceptor and donor, respectively), AAD is the
absorbance of the complex, eAD is the molar absorptivity of
the complex and KADC is the association constant of the
complex.
On plotting the values of [AO]/A
AD versus 1/[DO] straight
line was obtained (Fig. 2) whose intercept and the slope were
calculated and the following equations were obtained:rmination and thermodynamic studies of the charge transfer complexation of
3), http://dx.doi.org/10.1016/j.arabjc.2013.07.012
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Figure 2 Benesi–Hildebrand plot for DDQ, CA and TCNQ complexes.
4 A.-R.A. Sawsan et al.½Ao
AADk
¼ 19:95 105 þ 7 108  1½D0 DDQ complex
½Ao
AADk
¼ 39:79 105 þ 1:6 108  1½D0 CA complex
½Ao
AADk
¼ 3:221 105 þ 6 108  1½D0 TCNQ complex
The standard free energy change of complexation (DGo) is re-
lated to the association constant by the following equation
(Vogel’s, 1989; Martin and Swarbrick, 1969).
DG
 ¼ 2:303 RT log KADC
where DGo is the standard free energy of the complex (kcal/
mol), R is the gas constant (1.987 cal mol1 deg1), T is the
temp in Kelvin (273 + C) and KADC is the association constant
of complex (L/mol), (KADC ), (e
AD) and (DGo) were calculated
and the results are represented in Table 1.
3.3. Method validation (ICH Q2A, 1994; ICH Q2B, 1996)
3.3.1. Linearity and sensitivity
Under the speciﬁed optimum reaction conditions, the calibra-
tion curves for emedastine difumarate with the different Pi
acceptors employed in the present work were constructed.
The regression equations for the results were derived using
the least-squares method. In all cases, Beer’s law plots were lin-
ear in the concentration range of 5.0–100.0, 20.0–200.0, andTable 1 Association constant, molar absorptivity values and
calculated free energy from Benesi–Hildebrand plots for the
complexes formed.
Parameters DDQ CA TCNQ
Kc
AD(L/mol) 2.8 · 104 2.5 · 104 5.33 · 104
AD(L.mol1 cm1) 5.01 · 103 2.5 · 103 3.11 · 104
DG (kcal/mol) 6.09 10.14 7.3
Please cite this article in press as: Sawsan, A.-R.A. et al., Spectrophotometric dete
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and TCNQ, respectively with very small intercepts and good
correlation coefﬁcients in the speciﬁed concentration range
(Table 2). For accurate determination, Sandell sensitivities
were calculated which reﬂected the sensitivity and accuracy
of the proposed methods. The limits of detection (LOD) and
quantiﬁcation (LOQ) were determined, using the formula:
LOD= 3.3 r/S and LOQ= 10 r/S, where r= the standard
deviation of the intercepts of regression lines, S= the slope
of the calibration curve.
3.3.2. Accuracy and precision
The accuracy was evaluated by performing analysis of quality
control samples with known concentration level of emedastine
difumarate. The concentrations of the drug were calculated
from slope and intercept obtained from the corresponding
regression equation of the standard calibration curve. The
recovery percentages and the mean recovery were then calcu-
lated. Statistical comparison between the proposed spectro-
photometric and the ofﬁcial or manufacturer’s methods
using student’s t-test and F-ratio at the 95% conﬁdence level
reveals an insigniﬁcant difference (Table 3). The accuracy
was also assessed by applying the standard addition technique.
Satisfactory results were obtained in good agreement with the
labeled claim (Table 3).
The precisions of the assays (repeatability and intermediate
precision) were determined for emedastine difumarate concen-
trations. Repeatability was assessed by analyzing ﬁve concen-
tration levels in triplicates, using the proposed procedures,
where RSD were 0.427–0.82% (intra-assay precision). Inter-
mediate precision was evaluated by assaying the same concen-
trations in triplicate on three successive days. The assays gave
satisfactory results; the relative standard deviations (RSD)
were less than 2% (Table 2). This level of precision of the pro-
posed methods was adequate for the quality control analysis of
emedastine.
3.3.3. Ruggedness and robustness
The ruggedness of the proposed methods was assessed by
applying the procedures using two different instruments inrmination and thermodynamic studies of the charge transfer complexation of
3), http://dx.doi.org/10.1016/j.arabjc.2013.07.012
Table 3 Statistical analysis of the results obtained by the proposed charge transfer and ofﬁcial or manufacturer procedures for the
determination of emedastine difumarate in its drug substance and pharmaceutical formulation.
Values Drug substance Emedin eye drop
DDQ CA TCNQ Oﬃcial
methoda
DDQ CA TCNQ Manufac.
methodb
Mean 100.24 100.21 99.78 100.30 100.22 100.04 100.08 100.60
SD 0.498 0.497 0.746 0.819 0.589 0.680 0.719 0.938
SE 0.223 0.222 0.334 0.367 0.263 0.304 0.322 0.419
Variance 0.248 0.247 0.112 0.671 0.347 0.463 0.517 0.879
n 5 5 5 5 5 5 5 5
t-test (2.306)c 0.139 0.210 1.055 0.767 1.08 0.984
F-test (6.400)c 2.71 2.73 5.99 2.53 1.89 1.70
Standard addition mean ± RSD% 100.14 ± 0.96 100.67 ± 0.39 100.12 ± 0.91
a Ofﬁcial HPLC method (USP 2013).
b Manufacturer’s HPLC method.
c The values between parenthesis are the theoretical values of t and F at (p= 0.05).
Table 2 Spectral data and validation results for the reaction of emedastine difumarate with DDQ, CA and TCNQ.
Parameters DDQ CA TCNQ
kmax (nm) 457 519 841
Beer’s law limits (lg mL1) 5–100 20–200 0.8–16
Molar absorptivity (L mol1 cm1) 4.97 · 103 2.4 · 103 3.54 · 104
Sandell sensitivity (lg cm2) 0.107 0.223 0.015
Accuracy, n= 5, (mean ± RSD%) 100.24 ± 0.50 100.21 ± 0.47 99.78 ± 0.75
Precision, n= 15 Repeatability (mean ± RSD%) 99.88 ± 0.43 100.14 ± 0.60 100.67 ± 0.82
Intermediate precision (mean ± RSD%) 100.35 ± 0.55 100.08 ± 0.86 100.06 ± 0.78
Regression parameters
Slope ± SD 0.0094 ± 8.4 · 105 0.0045 ± 7.1 · 105 0.0661 ± 4.3 · 104
Intercept ± SD 0.0819 ± 5.5 · 104 0.0055 ± 8.4 · 105 0.00541 ± 1.1 · 104
SD of residual (Sxy) 8.7 · 103 5.6 · 103 3.9 · 103
Correlation coeﬃcient (r) 0.9996 0.9998 0.9999
LOD (lg mL1) 0.31 0.76 0.06
LOQ (lg mL1) 1.03 2.53 0.21
Spectrophotometric determination and thermodynamic studies of the charge transfer complexation 5two different laboratories at different elapsed time. Results
obtained from lab-to-lab and day-to-day variations were
found to be reproducible as RSD did not exceed 2%. Robust-
ness of the procedures was assessed by evaluating the inﬂuence
of small variation of experimental variables: concentrations of
reagents, and reaction time, on the analytical performance of
the method. In these experiments, one experimental parameter
was changed while the other parameters were kept unchanged,
and the recovery percentage was calculated each time. The
small variations in any of the variables did not signiﬁcantly af-
fect the results; recovery percentages were 99.78 ± 0.746–
100.21 ± 0.468%. This provided an indication for the reliabil-
ity of the proposed methods during routine work.
3.3.4. Application to pharmaceutical formulations
The obtained satisfactory validation results made the proposed
procedures suitable for the routine quality control analysis of
emedastine. The proposed method was applied for the determi-
nation of emedastine in its ophthalmic solution. The obtained
mean recoveries ± RSD% ranged from 100.04 ± 0.68 toPlease cite this article in press as: Sawsan, A.-R.A. et al., Spectrophotometric dete
emedastine difumarate with some p-acceptors. Arabian Journal of Chemistry (201100.22 ± 0.59. The methods were also assured by applying
the standard addition technique (Table 3). The results were
statistically compared with those obtained by the reported
method, proving no signiﬁcant difference with respect to accu-
racy and precision (Table 3).
3.4. Kinetic and thermodynamic parameters
The kinetic studies were carried out at different temperatures
(40, 50, and 60 C) for emedastine complex with TCNQ. The
plot of ln{(AiAt)/(AiA0)} as a function of time produced
straight line with slope equal to k. The equation gave the
best ﬁt for the experimental data corresponding to ﬁrst order
(Zhai et al., 2006). The straight lines revealed that the reac-
tion followed pseudo ﬁrst order, and the slope represents rate
constants (Fig. 3). Table 4, summaries the calculated k and
t1/2 at different temperatures, from which it is evident that
as the temperature increased the t1/2 decreased, proving
that at higher temperature the reaction was less time
consuming.rmination and thermodynamic studies of the charge transfer complexation of
3), http://dx.doi.org/10.1016/j.arabjc.2013.07.012
Table 5 Kinetic parameters for the reactions of emedastine
difumarate with TCNQ at different temperatures.
T(K) DSo (J mol1 K1). DHo (kJ mol1) DGo (kJ mol1)
313 51.26
323 51.84
333 1.809 4.902 52.42
Time (minutes)
5 10 15 20
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
ln
 A
i-
A
t/A
i 40 oC
50 oC
60 oC
Figure 3 Pseudo ﬁrst order plots for the reaction of 8.0 lg mL1
emedastine difumarate using 0.1% w/v TCNQ at 841 nm.
Table 4 Rate constant and half-life times of the studied
reactions at different temperatures.
T(K) k (min1) Intercept t1/2 (min) R
313 0.0407 0.1789 17.027 0.9996
323 0.0614 0.3229 11.29 0.9995
333 0.0944 0.3417 7.34 0.9994
6 A.-R.A. Sawsan et al.The relationship between the rate of reaction and tempera-
ture is determined by the Arrhenius equation:
k ¼ AeEa=RT
Ea is the activation energy, R= 8.314 J/mol K, T is the abso-
lute temperature in Kelvins, A is frequency factor (Abdellatef,
1998).
ln k ¼ Ea=RTþ lnA
Arrhenius curve for the studied drug with TCNQ was con-
structed by plotting ln k versus 1/T and it was found to be lin-
ear. The value of Ea was found to be 35.75 kJ/mol indicating
that the reactions need low activation energy, and ln A was
found to be 10.56. The other activation parameters such as en-
thalpy, entropy and free energy of activation were calculated
using the Eyring equation (Atkins, 1979; Stevens and Phil,
1970) which was applied in the following form;
ln k=T ¼ ðDH=RÞð1=TÞ þ ln kB=hþ DS=R
where kB is Boltzmann’s constant [1.381 · 1023 J K1] and h
is Plank’s constant [6.626 · 1034 J s], ln kB/h= 10.76.DHPlease cite this article in press as: Sawsan, A.-R.A. et al., Spectrophotometric dete
emedastine difumarate with some p-acceptors. Arabian Journal of Chemistry (201(kJ mol1) is activation enthalpy. DS (J mol1 K1) is
activation entropy. DG* (kJ mol1) is the free activation en-
thalpy (Gibb’s free energy).The Eyring plot of ln (k/T) versus
1/T produces a straight line. Activation parameters such as
enthalpy, entropy and free energy of activation of the reaction
were calculated and DS* from the intercept of Eyring plot:
DG* was calculated by using equation:
DG ¼ DH  T DS ð1Þ
The thermodynamic parameters are presented in Table 5. The
negative values of DS* at test reduce the freedom of motion in
the transition state and relatively slow the reaction that can be
followed spectrophotometrically. The positive values of DG*
indicate that the reactions are non-spontaneous.
4. Conclusion
The present work is concerned with the analysis of emedastine
difumarate in drug substance and pharmaceutical formula-
tions. In this paper charge-transfer reaction of emedastine as
n-electron donor with DDQ, CA and TCNQ as p-acceptors
has been investigated, using spectrophotometry methods.
The kinetic study of TCNQ by plotting ln k versus 1/T gives
straight line, reveals pseudo ﬁrst order and the thermodynamic
parameters reveal that the reaction of drug with TCNQ is non
spontaneous. On studying the molar ratio between drug and
each of, DDQ, CA and TCNQ, using Job’s method of contin-
uous variation, it was found to be 1:1. This indicates that only
one site is responsible for the formation of the complex and a
univalent charged species, is the possible site of the charge
transfer process.
In the literature, there is no other colorimetric method con-
cerned with the analysis of emedastine.
Unlike the most recommended HPLC-procedures, the pro-
posed spectrophotometric methods are simple, rapid and inex-
pensive. The procedures applied do not involve any critical
reactions or tedious sample preparations. This aspect is of ma-
jor interest in analytical pharmacy.
High values of correlation coefﬁcients and small values of
intercepts validated the linearity of the calibration graphs
and the obedience to beer’s law. The RSD values, the slopes
and the intercepts of calibration graphs indicated the high
reproducibility of the proposed methods.
From the results obtained, we concluded that the suggested
methods showed high accuracy, reproducibility, simplicity and
inexpensiveness, permitting their application in quality control
laboratories.References
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